Sign up for the QMED & MD+DI Daily newsletter.
New Study Says DES Are Safer Than Thought
A study in the British journal The Lancet says that patients who receive drug-eluting stents are no more likely to die than those who receive bare-metal stents, reports the New York Times. That could temper fears about blood-clotting risks. Or maybe not. Once a negative message gets out there, it's hard to make it go away.
September 14, 2007
1 Min Read
The study does have negative news for Boston Scientific: It says that patients with Taxus are more likely to suffer heart attacks than patients with J&J's Cypher. It also says that Taxus patients are slightly more likely to get blood clots than patients with Cypher or bare-metal stents.
You May Also Like
Pedersen's POV graphic featuring the headshot of MD+DI Senior Editor Amanda Pedersen and a pull quote from the latest edition of her opinion column.
BioSig's Ridiculously Sparse Layoff Announcement Reeks of CallousnessFeb 26, 2024|3 Min Read
Sourcing Electrical Components: Are We Back to Normal?Feb 26, 2024|6 Min Read
Your Smartwatch Can’t Measure Blood Glucose Levels… YetFeb 26, 2024|3 Min Read
Medtech in a Minute: Medtronic Pulls the Plug on Ventilators and MoreFeb 26, 2024|1 Min Read